Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide

Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide

<b><i>Background</i> & <i>Objectives</i>:</b> Targeted-release budesonide (TRB) is the first approved agent aimed at targeting the early pathogenetic cascade in IgA nephropathy (IgAN). <b><i>Materials and Methods</i>:</b> This prospecti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Christodoulos Keskinis, Eleni Moysidou, Stamatia Stai, Michalis Christodoulou, Georgios Lioulios, Sotirios-Spyridon Vamvakas, Maria Stella Trivyza, Panagiotis Pateinakis, Marios Papasotiriou, Maria Stangou
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Medicina
Subjects:	IgA nephropathy targeted-release budesonide urinary biomarkers Monocyte Chemotactic Protein-1 (MCP-1) Matrix MetalloProteinase-9 (MMP-9) clusterin (CLU)
Online Access:	https://www.mdpi.com/1648-9144/61/5/807
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clusterin facilitates glioma progression via BCL2L1-dependent regulation of apoptotic resistance
by: Qingqing Xu, et al.
Published: (2025-06-01)

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010-02-01)

Clusterin induced by OPC phagocytosis blocks IL-9 secretion to inhibit myelination in a model of Alzheimer's disease
by: Rebecca M. Beiter, et al.
Published: (2025-01-01)

Protocol Biopsies in Kidney Transplant Recipients: Current Practice After Much Discussion
by: Christina Lazarou, et al.
Published: (2025-07-01)

T-Follicular Helper Cells and Their Role in Autoimmune Diseases
by: Michalis Christodoulou, et al.
Published: (2025-04-01)

Improving Pulmonary Delivery of Budesonide Suspensions Nebulized with Constant-Output Vibrating Mesh Nebulizers by Using Valved Holding Chamber
by: Tomasz R. Sosnowski, et al.
Published: (2025-05-01)

Budesonide in treatment of alcohol-induced severe hepatitis: results of randomized trial
by: I. I. Komkova, et al.
Published: (2013-09-01)

Exploring the molecular mechanism of budesonide enteric capsules in the treatment of IgA nephropathy based on bioinformatics
by: Mengshu Lin, et al.
Published: (2025-08-01)

Efficacy of budesonide suspension in the treatment of lobar pneumonia by fiberoptic bronchoscopic alveolar lavage
by: Xin Ji, et al.
Published: (2025-06-01)

Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age
by: Sedigheh Ekraminasab, et al.
Published: (2025-04-01)

The efficacy and safety of acetylcysteine combined with budesonide nebulization in treating mycoplasma pneumonia in children: a meta-analysis
by: Yinan He, et al.
Published: (2025-06-01)

Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia
by: Minji Heo, et al.
Published: (2020-08-01)

Matrix Metalloproteinase 9 as Biomarker for Malignant Mammary Tumors in Dogs
by: Islam S Alani, et al.
Published: (2024-12-01)

EFFECT OF SILVER NANOPARTICLES IN EXPERIMENTAL PERITONITIS
by: D. V. Chegodar, et al.
Published: (2015-04-01)

Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU
by: Xin Hu, et al.
Published: (2025-02-01)

Eﬀect of the combination of theophylline and budesonide on production of proinﬂammatory cytokines by blood cells of patients with chronic obstructive pulmonary disease
by: A. G. Kadushkin, et al.
Published: (2021-11-01)

Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
by: Nan Shang, et al.
Published: (2024-12-01)

Investigating the Relationship between Changes in the Expression Level of the CLU Gene and the Prognosis of Gastric Cancer Patients
by: Arezoo Farhadi, et al.
Published: (2024-10-01)

Effect of Liu Wei Di Huang Wan on RAGE,MCP-1 and Fractalkine in blood and urine of patients with lupus nephritis
by: ZHANG Ya-nan
Published: (2017-01-01)

Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation
by: E. A. Sergeev, et al.
Published: (2022-05-01)

Characteristics of Patients Receiving Budesonide/Glycopyrronium/Formoterol for Chronic Obstructive Pulmonary Disease in Spain: The AURA Study
by: Calle Rubio M, et al.
Published: (2025-04-01)

The chemotactic response of Caenorhabditis elegans represents a promising tool for the early detection of cancer
by: Alžbeta Kaiglová, et al.
Published: (2024-12-01)

Real-Life Effectiveness of Budesonide/Formoterol as Maintenance and Reliever Treatment via the Elpenhaler® Device in Patients with Asthma: The NOTOS Observational Study
by: Gogali A, et al.
Published: (2025-04-01)

Plasma Levels of CXCL9 and MCP-3 are Increased in Asthma-COPD Overlap (ACO) Patients
by: Escamilla-Gil JM, et al.
Published: (2025-04-01)

Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study
by: Deslee G, et al.
Published: (2025-04-01)

Age-associated level of myocardial fibrosis markers and chemokines in patients with acute coronary syndrome
by: O. A. Osipova, et al.
Published: (2021-09-01)

The treatment of patients with asthma and comorbidity.
by: G. V. Yeryomenko, et al.
Published: (2018-04-01)

Bran from composite grain mixture as an object of deep processing. Part 1. Protein-proteinase complex
by: I. S. Vitol, et al.
Published: (2023-01-01)

Topical Dudesonide Rnse for Postoperative Care in Chronic Rhino-Sinusitis with and without Polyp
by: Dlbrin Mala Mohammed Mala Ghafour, et al.
Published: (2023-05-01)

Clusterin ameliorates diabetic atherosclerosis by suppressing macrophage pyroptosis and activation
by: Lingling Xuan, et al.
Published: (2025-04-01)

Clusterin mediates hydroquinone-induced cytotoxic responses in HL-60 differentiated cells
by: Peimao Li, et al.
Published: (2024-12-01)

Non-Invasive Biomarkers for Early Diagnosis of Kidney Allograft Dysfunction: Current and Future Applications in the Era of Precision Medicine
by: Christina Lazarou, et al.
Published: (2025-02-01)

Microscopic Colitis: A Clinical Case
by: E. V. Reznik, et al.
Published: (2023-04-01)

Optimization of a Treatment Protocol for Acute Stenosing Laryngitis in Children
by: L. V. Kramar, et al.
Published: (2016-11-01)

Numerical Simulation of Organic Pollution Migration in the Heterogeneous Aquifer and the Application of Chemotactic Bacteria for Remediation: A Case Study of a Chemical Contamination Site in Zhejiang Province, China
by: Shaohua Cao, et al.
Published: (2024-10-01)

Detection of Monocyte Chemotactic Protein-1 (MCP-1) among Patients with Celiac Disease
by: Yasser Abdul Hamza Ali Al-Timimi, et al.
Published: (2025-06-01)

Curcumin-Induced Apoptotic Cell Death in Human Glioma Cells Is Enhanced by Clusterin Deficiency
by: Pinky Sultana, et al.
Published: (2025-05-01)

Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation
by: Hye-Young Seo, et al.
Published: (2025-03-01)

Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils
by: Alice Filippini, et al.
Published: (2025-05-01)

Postnatal corticosteroids to prevent bronchopulmonary dysplasia: balancing benefits and risks. A narrative review
by: Gustavo Rocha
Published: (2025-04-01)